Posted on

CJC-1295 Clinical Research: Human Trials, DAC Technology, and Safety Findings

3D visualization of a modified peptide molecule conjugating to a serum albumin protein structure.

CJC-1295 is an investigational growth hormone-releasing hormone analogue engineered with Drug Affinity Complex technology for extended half-life. While ear

Read more CJC-1295 Clinical Research: Human Trials, DAC Technology, and Safety Findings